Drugs

Latest

What the African Medicines Agency Needs Most to Succeed

The formation of the AMA is a milestone for drug safety and trust in Africa

Britain's Moral Bankruptcy Over COVID-19 Vaccines

Why a study set to deliberately infect people with coronavirus is unethical, unnecessary, and likely to be uninformative

Trade

Back to Basics After COVID-19

Investing in Primary Care Now Will Prepare the U.S. for the Next Pandemic

Poverty

Who Gets What and Why?

Countries need informed decision-making through health technology assessment to allocate resources during the pandemic

Trade

Vaccine Nationalism and Africa

African Union calls for a “People's Vaccine” as African Academy of Sciences begins mapping local clinical trials sites

Trade

Patent Pools and the Pandemic—A Renewed Debate

In light of COVID-19 we need to revisit patent pools and their potential for pro-competitive and anticompetitive effects

Trade

Vaccine Dreams and Russian Reality

Putin's gamble on an untested cure has high stakes—it could pay off if it actually works but will cost lives if it fails

Aging

Mothers, Children, and the Terrible Choice Between COVID-19 and Other Infections

Decisive action is required now to protect the most vulnerable from HIV, tuberculosis, and malaria during the pandemic

Trade

Coronavirus is a Public Health Nightmare—Now Comes One More

As the pandemic chokes off opioid supplies from China and unemployment skyrockets, U.S. meth addiction is set to explode

Poverty

Rethinking the Future of Global Health

There can be no better time to reimagine our health security based on global cooperation, equity, trust, and solidarity

Trade

Coronavirus Drugs—To Have and Have Not

Africa's least developed countries should apply a WTO patent waiver, to import generic versions of future COVID-19 drugs

Governance

How to Future-Proof Medical Supplies

Building resilience in COVID-19's wake will require multiple strategies, including strengthening our medical stockpile

Trade

Six Proactive Steps in a Smart Trade Approach to Fighting COVID-19

Tariffs, subsidies, waivers, licensure, and what a trade agenda to support the fight against coronavirus might look like